Agensys

Pioneering advanced treatments for cancer with innovative therapeutic antibodies and drug conjugates.

General Information
Company Name
Agensys
Founded Year
1997
Location (Offices)
Founders / Decision Makers
Number of Employees
-
Industries
Biotechnology, Health Care, Pharmaceutical
Funding Stage
Series D
Social Media

Agensys - Company Profile

Agensys is a pioneering biotechnology company focusing on the research and development of therapeutic human monoclonal antibodies and antibody-drug conjugates aimed at treating cancer. Established in 1997 and formerly known as UroGenesys, the company is headquartered in Santa Monica, California. Agensys has gained traction in the biotechnology and pharmaceutical industries, targeting various tumors, including prostate, pancreatic, and bladder cancers. In July 2007, the company secured a significant $41.30M Series D investment led by HBM Healthcare Investments, Jafco Ventures, Alta Partners, OrbiMed, Nextech Invest, Bear Stearns, Tekla Capital Management, Innovis Investments, Lombard Odier, and Duquesne Capital Management. Agensys has been a subsidiary of Astellas Pharma US, Inc. since December 18, 2007. The company's slogan reflects its core mission of innovating advanced treatments for cancer with innovative therapeutic antibodies and drug conjugates.

Taxonomy: cancer treatment, therapeutic antibodies, monoclonal antibodies, drug conjugates, oncology research, tumor targeting, prostate cancer, pancreatic cancer, bladder cancer, Santa Monica, Astellas Pharma, biopharmaceutical, innovation

Funding Rounds & Investors of Agensys (5)

View All
Funding Stage Amount No. Investors Investors Date
Series D $41.30M 10 Bear Stearns, Tekla Capital Management +3 12 Jul 2007
Debt Financing $3.00M - 05 Mar 2003
Series C $42.80M - 04 Mar 2002
Series B $11.30M - 11 Oct 1999
Series A $8.00M - 10 Nov 1997

Latest News of Agensys

View All

No recent news or press coverage available for Agensys.

Similar Companies to Agensys

View All
Alethia Biotherapeutics Inc. - Similar company to Agensys
Alethia Biotherapeutics Inc. Immunotherapeutics against disease-specific targets
Galileo Biotech - Similar company to Agensys
Galileo Biotech "Powering the Leading-Edge of Biotherapeutics"
Adagene - Similar company to Agensys
Adagene Redefining the design and discovery of therapeutic antibodies
ProMab Biotechnologies, Inc. - Similar company to Agensys
ProMab Biotechnologies, Inc. Your Trusted Partner for Cutting-Edge Antibody, mRNA-LNP Solutions, and Immunotherapy Breakthroughs.